Pages that link to "Q79811373"
Jump to navigation
Jump to search
The following pages link to Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization (Q79811373):
Displaying 50 items.
- Prevalence of chronic kidney disease in population-based studies: systematic review (Q21257215) (← links)
- Association between shiftwork and glomerular filtration rate in police officers (Q23917173) (← links)
- Antiplatelet agents for chronic kidney disease (Q24200752) (← links)
- Antiplatelet agents for chronic kidney disease (Q24234115) (← links)
- Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy (Q24657470) (← links)
- Guidelines for the management of chronic kidney disease (Q24657844) (← links)
- Barriers to successful care for chronic kidney disease (Q24810614) (← links)
- Chronic kidney disease and risk factors responsible for sudden cardiac death: a whiff of hope? (Q26748992) (← links)
- The Role of the Multiple Hormonal Dysregulation in the Onset of "Anemia of Aging": Focus on Testosterone, IGF-1, and Thyroid Hormones (Q26771431) (← links)
- Cardiorenal syndrome: the emerging role of protein-bound uremic toxins (Q26830674) (← links)
- Antihypertensive treatment and renal protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system (Q26865691) (← links)
- Blood Pressure Control in Patients with Chronic Kidney Disease (Q27010229) (← links)
- Understanding the implementation of interventions to improve the management of chronic kidney disease in primary care: a rapid realist review (Q28070029) (← links)
- Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state (Q28081493) (← links)
- Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein (Q28083619) (← links)
- The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease (Q28382992) (← links)
- Ageing Renal Patients: We Need More Collaboration between Geriatric Services and Nephrology Departments (Q28383409) (← links)
- Immunoglobulin (Ig)M antibodies against oxidized cardiolipin but not native cardiolipin are novel biomarkers in haemodialysis patients, associated negatively with mortality (Q28390958) (← links)
- Effects of Allicin on Hypertension and Cardiac Function in Chronic Kidney Disease (Q28395796) (← links)
- Evolution of Cardiovascular Disease During the Transition to End-Stage Renal Disease (Q30234797) (← links)
- Protection against death and renal failure by renin-angiotensin system blockers in patients with diabetes and kidney disease (Q30249156) (← links)
- Interstate Variation in Receipt of Nephrologist Care in US Patients Approaching ESRD: Race, Age, and State Characteristics (Q30278550) (← links)
- Diagnosis and treatment of chronic kidney disease (Q30313435) (← links)
- The Prevalence of Renal Failure. Results from the German Health Interview and Examination Survey for Adults, 2008-2011 (DEGS1). (Q30315516) (← links)
- Racial differences in estimated GFR decline, ESRD, and mortality in an integrated health system (Q30411449) (← links)
- Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease (Q30435250) (← links)
- Outcomes associated with race in males with nondialysis-dependent chronic kidney disease (Q30436226) (← links)
- Ageism vs. the technical imperative, applying the GRADE framework to the evidence on hemodialysis in very elderly patients (Q30541143) (← links)
- Evaluation of cardiovascular disease burden and therapeutic goal attainment in US adults with chronic kidney disease: an analysis of national health and nutritional examination survey data, 2001-2010. (Q30651756) (← links)
- Randomized multicentre pilot study of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: United Kingdom Heart and Renal Protection (HARP)- III-rationale, trial design and baseline data (Q31131772) (← links)
- Hepatitis C virus infection increases risk of developing end-stage renal disease using competing risk analysis. (Q31168457) (← links)
- Doppler assessment of brachial artery flow as a measure of endothelial dysfunction in pediatric chronic renal failure (Q33342286) (← links)
- High prevalence of chronic kidney disease in Iran: a large population-based study (Q33404464) (← links)
- Association of kidney function and uncarboxylated matrix Gla protein: data from the Heart and Soul Study (Q33407103) (← links)
- Prevalence of chronic kidney disease in Thai adults: a national health survey (Q33514125) (← links)
- Longitudinal relationships among coronary artery calcification, serum phosphorus, and kidney function (Q33560460) (← links)
- Renal Function and Death in Older Women: Which eGFR Formula Should We Use? (Q33561046) (← links)
- Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study). (Q33562005) (← links)
- The role of novel biomarkers of cardiovascular disease in chronic kidney disease: focus on adiponectin and leptin (Q33572275) (← links)
- Effect of lovastatin on primary prevention of cardiovascular events in mild CKD and kidney function loss: a post hoc analysis of the Air Force/Texas Coronary Atherosclerosis Prevention Study (Q33578185) (← links)
- Tryptophan Metabolism in Patients With Chronic Kidney Disease Secondary to Type 2 Diabetes: Relationship to Inflammatory Markers (Q33585122) (← links)
- Higher fibroblast growth factor-23 concentrations associate with left ventricular systolic dysfunction in dialysis patients (Q33600110) (← links)
- Risk factors of one year increment of coronary calcifications and survival in hemodialysis patients (Q33611410) (← links)
- Extra-skeletal effects of vitamin D deficiency in chronic kidney disease (Q33649014) (← links)
- Risk factors for chronic kidney disease among American Indians and Alaska Natives--findings from the Kidney Early Evaluation Program (Q33653126) (← links)
- Impact of cardiovascular calcification in nondialyzed patients after 24 months of follow-up (Q33684130) (← links)
- The association between urbanization and reduced renal function: findings from the China Health and Nutrition Survey (Q33691471) (← links)
- Cardiovascular complications of diabetic kidney disease. (Q33711038) (← links)
- Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar (Q33721299) (← links)
- Early nephrology referral reduces the economic costs among patients who start renal replacement therapy: a prospective cohort study in Korea (Q33753728) (← links)